Microsoft Discovery
AI overview
Sign in and the AI will write an overview from our coverage.
Headlines · 1
- Big Tech Moves Into AI Drug Development
TMTPost reported that Anthropic announced the acquisition of one-employee biotechnology company Mithril Medicine, which studies treatments for two rare muscular dystrophies. OpenAI also announced the acquisition of Orchestra Bio and plans to integrate its drug-development workflow coordination technology into Rosalind. Other initiatives include Isomorphic Labs’ drug pipeline, Nvidia and Eli Lilly’s planned AI laboratory, Amazon and Novo Nordisk’s strategic partnership, and Microsoft Discovery. Mithril Medicine’s reported mouse results are preclinical, and its potential entry into human trials by the end of 2028 remains conditional on further research.
钛媒体 · 🔥 0
Experience and discussion from the community
Share my Microsoft Discovery experienceAsk about Microsoft Discovery
Nobody has shared their experience with Microsoft Discovery yet.